Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-26-001397·CAPRICOR THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Capricor Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 14070B309
Event date: 2026-02-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SUVRETTA CAPITAL MANAGEMENT, LLC
Shares: 3,417,891.00 · Class: 6.6%
- Averill Master Fund, Ltd.
Shares: 2,917,420.00 · Class: 5.6%
- Aaron Cowen
Shares: 3,417,891.00 · Class: 6.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-001397
- Form type
- SCHEDULE 13G
- Filer
- CAPRICOR THERAPEUTICS, INC.
- CIK
- CIK 1133869
- Filed
- Feb 26, 2026
- Reporting period
- Feb 19, 2026
- Description
- Schedule 13G beneficial ownership